DDInter1782 DDInter1371
Tetracosactide (also known as Cosyntropin) is a synthetic peptide that is identical to the 24-amino acid segment (sequence: SYSMEHFRWGKPVGKKRRPVKVYP) at the N-terminal of adrenocorticotropic hormone. ACTH (1-24), a segment similar in all species, contains the biological activity that stimulates production of corticosteroids in the adrenal cortex. Tetracosactide exhibits the same activity as natural ACTH with regard to all its biological activities. The complex results in a product whose absorption in man is effected over a longer period of time as compared to corticotropin. Therefore, therapy may be maintained with less frequent administration.
Oxymetholone is a synthetic anabolic steroid marketed under the brand name Anapolon by Hoffmann La Roche Limitedand used in the treatment of osteoporosis, anaemia, and as an agent to stimulate muscle growth in malnourished or underdeveloped patients. Anabolic-androgenic steroids (AAS), such as oxymetholone, have been abused by bodybuilders and athletes. The uncontrolled misuse of oxymetholone can lead to a large variety of detrimental effects, the most often reported of which are cardiovascular events. In 2009, no producers of oxymetholone were identified worldwide (SRI 2009), but it was available from 14 suppliers, including 8 U.S. suppliers (ChemSources 2009).
Tetracosactide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Racepinephrine
Tetracosactide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Salmeterol
Tetracosactide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Pentobarbital
Tetracosactide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Ustekinumab
Tetracosactide {u} may lead to a major life threatening interaction when taken with {v} Etanercept
Tetracosactide {u} may lead to a major life threatening interaction when taken with {v} Fingolimod
Tetracosactide may cause a minor interaction that can limit clinical effects when taken with Racepinephrine
Tetracosactide may cause a minor interaction that can limit clinical effects when taken with Salmeterol
Tetracosactide may cause a moderate interaction that could exacerbate diseases when taken with Pentobarbital
Tetracosactide may cause a moderate interaction that could exacerbate diseases when taken with Ustekinumab
Tetracosactide may lead to a major life threatening interaction when taken with Etanercept
Tetracosactide may lead to a major life threatening interaction when taken with Fingolimod